Gelesis Holdings Inc., (GLS): Price and Financial Metrics
GLS Price/Volume Stats
| Current price | $0.16 | 52-week high | $5.71 |
| Prev. close | $0.16 | 52-week low | $0.11 |
| Day low | $0.15 | Volume | 185,100 |
| Day high | $0.16 | Avg. volume | 386,034 |
| 50-day MA | $0.24 | Dividend yield | N/A |
| 200-day MA | $0.72 | Market Cap | 11.63M |
GLS Stock Price Chart Interactive Chart >
Gelesis Holdings Inc., (GLS) Company Bio
Gelesis Holdings Inc., a biotherapeutics company, developing a novel category of treatments for weight management and gut related chronic diseases. It develops a mechanobiology technology platform to treat obesity and other chronic diseases related to the GI pathway. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and chronic idiopathic constipation. Gelesis Holdings Inc. was incorporated in 2006 and is based in Boston, Massachusetts.
GLS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -98.39% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -97.08% |
| 2021 | -1.87% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...